SynthesisContact dermatitis2025
Prevalence of Contact Allergy to Rubber Accelerators From the European Baseline Series in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Synthesis in Contact dermatitis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prevalence of Contact Allergy to Colophonium in Dermatitis Patients: A Systematic Review and Meta-Analysis.Contact dermatitis · 2026Pooled it
- Prevalence of Contact Allergy to Isothiazolinones in Dermatitis Patients From 2000 to 2025: A Systematic Review and Meta-Analysis.Contact dermatitis · 2026Pooled it
- Prevalence of Contact Allergy to Rubber Accelerators From the European Baseline Series in Dermatitis Patients: A Systematic Review and Meta-Analysis.Contact dermatitis · 2025Pooled it
- Occupational Contact Dermatitis in the Post-COVID Era: From Barrier Dysfunction and Microbiome Dysbiosis to Prevention and Precision Management.Journal of clinical medicine · 2026Review
- A Parade of Persistent and Emerging Contact Allergens - A Clinical Update.Current allergy and asthma reports · 2026Review
- Contact Dermatitis among Hospital Cleaners in Dar es Salaam: Prevalence and Associated Factors.Malawi medical journal : the journal of Medical Association of Malawi · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rubber accelerators are chemicals used as vulcanizers in the production of rubber items and may cause contact allergy (CA). The aim of this study was to assess the worldwide prevalence of CA to rubber accelerators from the European baseline series among dermatitis patients. A comprehensive literature search across PubMed, Embase, and Web of Science yielded 106 studies with 826 543 individuals patch tested between 1984 and 2023. Meta-analysis showed pooled prevalence rates of 2.55% for thiuram mix, 0.86% for mercapto mix, and 0.83% for mercaptobenzothiazole. Marked geographical variations were observed: North America and Asian regions showed the highest prevalences whereas Europe had lower rates. Comparisons before and after the year 2000 revealed a decline in CA to all three accelerators. Sub-analysis of the extended rubber series revealed the prevalence of CA to tetraethylthiuram disulphide of 3.73% and to zinc diethyldithiocarbamate of 0.60%. The prevalence of CA to carba mix was 3.96%. These findings underscore the public health implications of rubber accelerator-induced CA. Strengthened preventive measures and regulatory efforts, including improved labelling, safe limits of rubber gloves, and reduced use of high-risk accelerators are needed to mitigate disease burden. The results emphasise a need for ongoing surveillance, especially concerning extended rubber series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.